The antibody bound specifically to MSLN according to the present invention can develop an antibody to be effectively used for treating or diagnosing cancer or tumor diseases due to high affinity and specificity with respect to antigen.KIM, DONG SIK...
which is opposite to an antigen binding site, from the viewpoint of decreasing an effect on the antibody or fragment's binding capacity and specificity to MSLN, and the like. When the whole antibody, rather than a fragment thereof, is used, the drug may ...
(R&D Systems) | seven hills bioreagents | zytovision | zyagen Laboratories | ZeptoMetrix | WSU Monoclonal Antibody Center | VMRD | VitaNavi | Virusys | Usbiological | UBPBIO | tulip biolabs | TriLink BioTechnologies | TRC | Ted Pella | swant | steraloids | ST john's laboratory | Sphero...